Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil Sharrack

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 18, 2014
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activationDongsheng Wu, Camilla Cerutti, Miguel A Lopez-Ramirez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72Azza Ismail, Johnathan Cooper-Knock, J Robin Highley, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 27, 2024
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studiesBart Van Wijmeersch, Barry A Singer, Aaron Boster, et al.
Neurology and Therapy|June 24, 2021
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS StudiesSamuel F Hunter, Rany A Aburashed, Raed Alroughani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Measuring coping in multiple sclerosis: The Coping Index-MSCarolyn A Young, Roger J Mills, Dawn Langdon, et al.
British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.
Frontiers in Bioengineering and Biotechnology|June 20, 2022
An Algorithm for Accurate Marker-Based Gait Event Detection in Healthy and Pathological Populations During Complex Motor TasksTecla Bonci, Francesca Salis, Kirsty Scott, et al.
The Lancet. Neurology|January 30, 2016
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trialRhian Raftopoulos, Simon J Hickman, Ahmed Toosy, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 18, 2014
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activationDongsheng Wu, Camilla Cerutti, Miguel A Lopez-Ramirez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72Azza Ismail, Johnathan Cooper-Knock, J Robin Highley, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 27, 2024
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomas Kalincik, Sifat Sharmin, Izanne Roos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studiesBart Van Wijmeersch, Barry A Singer, Aaron Boster, et al.
Neurology and Therapy|June 24, 2021
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS StudiesSamuel F Hunter, Rany A Aburashed, Raed Alroughani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Measuring coping in multiple sclerosis: The Coping Index-MSCarolyn A Young, Roger J Mills, Dawn Langdon, et al.
British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.
Frontiers in Bioengineering and Biotechnology|June 20, 2022
An Algorithm for Accurate Marker-Based Gait Event Detection in Healthy and Pathological Populations During Complex Motor TasksTecla Bonci, Francesca Salis, Kirsty Scott, et al.
The Lancet. Neurology|January 30, 2016
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trialRhian Raftopoulos, Simon J Hickman, Ahmed Toosy, et al.
Pageof 16